Dupont Capital Management Has Lifted By $753,844 Its Ppg Industries (PPG) Position; 12 Analysts Are Bullish Cytokinetics, Inc. (CYTK) Last Week

October 13, 2017 - By Marie Mckinney

Among 12 analysts covering Cytokinetics (NASDAQ:CYTK), 12 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cytokinetics had 15 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co on Thursday, August 3 with “Buy”. The stock of Cytokinetics, Inc. (NASDAQ:CYTK) has “Buy” rating given on Wednesday, July 27 by Needham. On Tuesday, November 10 the stock rating was maintained by FBR Capital with “Outperform”. The firm earned “Buy” rating on Friday, July 24 by MLV. The rating was maintained by Morgan Stanley on Friday, October 6 with “Overweight”. On Monday, November 9 the stock rating was maintained by TH Capital with “Buy”. Cantor Fitzgerald initiated it with “Overweight” rating and $21 target in Friday, December 16 report. Needham maintained the shares of CYTK in report on Friday, September 15 with “Buy” rating. H.C. Wainwright maintained it with “Buy” rating and $2600 target in Thursday, August 3 report. On Wednesday, March 9 the stock rating was maintained by JMP Securities with “Market Outperform”. See Cytokinetics, Inc. (NASDAQ:CYTK) latest ratings:

10/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $24.0 Maintain
06/10/2017 Broker: Seaport Global Rating: Buy New Target: $24 Initiates Coverage On
06/10/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $24 New Target: $25 Maintain
18/09/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $21.0
15/09/2017 Broker: Needham Rating: Buy New Target: $22.0 Maintain
03/08/2017 Broker: Cowen & Co Rating: Buy New Target: $19.0000 Maintain
03/08/2017 Broker: H.C. Wainwright Rating: Buy New Target: $26.0000 Maintain

Dupont Capital Management Corp increased Ppg Industries Inc (PPG) stake by 6.08% reported in 2017Q2 SEC filing. Dupont Capital Management Corp acquired 6,916 shares as Ppg Industries Inc (PPG)’s stock rose 4.26%. The Dupont Capital Management Corp holds 120,591 shares with $13.26M value, up from 113,675 last quarter. Ppg Industries Inc now has $29.18 billion valuation. The stock increased 0.86% or $0.97 during the last trading session, reaching $113.4. About shares traded. PPG Industries, Inc. (NYSE:PPG) has risen 1.03% since October 13, 2016 and is uptrending. It has underperformed by 15.67% the S&P500.

Dupont Capital Management Corp decreased Cummins Inc (NYSE:CMI) stake by 15,197 shares to 16,385 valued at $2.66M in 2017Q2. It also reduced Quanta Services Inc (NYSE:PWR) stake by 106,018 shares and now owns 39,179 shares. Norfolk Southern Corp (NYSE:NSC) was reduced too.

Investors sentiment decreased to 0.8 in 2017 Q2. Its down 0.06, from 0.86 in 2017Q1. It dropped, as 47 investors sold PPG shares while 252 reduced holdings. 64 funds opened positions while 176 raised stakes. 185.24 million shares or 3.67% more from 178.68 million shares in 2017Q1 were reported. Cambridge Communication reported 0.04% of its portfolio in PPG Industries, Inc. (NYSE:PPG). 1,561 were reported by First Personal Fincl Services. Da Davidson Company holds 0.19% or 76,296 shares. Provident Trust owns 3,984 shares. Mcrae Mngmt reported 0.15% of its portfolio in PPG Industries, Inc. (NYSE:PPG). Pittenger Anderson owns 37,145 shares. Fincl Bank Of New York Mellon Corp reported 2.53 million shares or 0.08% of all its holdings. Fort Washington Inv Incorporated Oh holds 0.01% or 5,040 shares. Piedmont Invest Advsr Limited Co holds 0.13% or 54,770 shares in its portfolio. Apg Asset Mgmt Nv reported 490,698 shares stake. Moreover, Washington Co has 0.02% invested in PPG Industries, Inc. (NYSE:PPG). Veritable Lp owns 15,850 shares for 0.04% of their portfolio. South State reported 5,172 shares stake. Northwestern Mutual Wealth Management Co has 0.01% invested in PPG Industries, Inc. (NYSE:PPG) for 7,311 shares. Pictet Asset Management, United Kingdom-based fund reported 245,154 shares.

Among 21 analysts covering PPG Industries (NYSE:PPG), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. PPG Industries had 45 analyst reports since September 6, 2015 according to SRatingsIntel. Citigroup downgraded the stock to “Neutral” rating in Monday, January 9 report. The rating was maintained by RBC Capital Markets on Monday, August 7 with “Hold”. Atlantic Securities upgraded the shares of PPG in report on Wednesday, March 15 to “Overweight” rating. Jefferies maintained it with “Buy” rating and $120.0 target in Friday, September 15 report. The company was downgraded on Tuesday, December 13 by RBC Capital Markets. The rating was downgraded by Bank of America to “Neutral” on Monday, July 24. The firm earned “Outperform” rating on Wednesday, November 25 by RBC Capital Markets. SunTrust downgraded PPG Industries, Inc. (NYSE:PPG) on Monday, July 24 to “Hold” rating. On Tuesday, October 25 the stock rating was downgraded by Argus Research to “Hold”. The rating was upgraded by Longbow on Thursday, June 23 to “Buy”.

Since June 1, 2017, it had 0 insider purchases, and 1 insider sale for $68,093 activity. Blum Robert I also sold $68,093 worth of Cytokinetics, Inc. (NASDAQ:CYTK) shares.

Cytokinetics, Incorporated is a late-stage biopharmaceutical company. The company has market cap of $839.88 million. The Firm is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It currently has negative earnings. It is focused on the discovery and development of small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions.

Investors sentiment increased to 2.94 in Q2 2017. Its up 1.33, from 1.61 in 2017Q1. It is positive, as 14 investors sold Cytokinetics, Inc. shares while 17 reduced holdings. 44 funds opened positions while 47 raised stakes. 37.79 million shares or 34.95% more from 28.00 million shares in 2017Q1 were reported. Morgan Stanley stated it has 0% in Cytokinetics, Inc. (NASDAQ:CYTK). Arizona State Retirement has 24,130 shares for 0% of their portfolio. United Service Automobile Association has 0.01% invested in Cytokinetics, Inc. (NASDAQ:CYTK) for 164,280 shares. Wellington Grp Llp has 0.01% invested in Cytokinetics, Inc. (NASDAQ:CYTK). Laurion Cap Mngmt Ltd Partnership has 0.02% invested in Cytokinetics, Inc. (NASDAQ:CYTK) for 324,693 shares. Sector Pension Board holds 0% of its portfolio in Cytokinetics, Inc. (NASDAQ:CYTK) for 25,000 shares. Fortaleza Asset Mngmt accumulated 10,345 shares. Moreover, Barclays Public Limited Co has 0% invested in Cytokinetics, Inc. (NASDAQ:CYTK) for 24,466 shares. Retail Bank Of Montreal Can stated it has 23,535 shares or 0% of all its holdings. Wade G W And Incorporated, a Massachusetts-based fund reported 20,000 shares. Guggenheim Capital Ltd reported 113,255 shares. Proshare Advsrs Lc holds 0% in Cytokinetics, Inc. (NASDAQ:CYTK) or 27,501 shares. Ironwood Investment Management reported 114,262 shares. Great West Life Assurance Commerce Can accumulated 66,700 shares. Ameriprise has invested 0% of its portfolio in Cytokinetics, Inc. (NASDAQ:CYTK).

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>
Twitter Auto Publish Powered By : XYZScripts.com